While no association was observed between use of biologics and incident PsA overall, specific biologic classes were ...

Metabolic syndrome is associated with a greater risk for excessive scarring, with several specific metabolic components linked to higher risk.

Cutaneous lupus erythematosus is a chronic autoimmune disease with few treatment options and no approved targeted therapies.

Bemotrizinol, recently approved as a new active ingredient in sunscreens, is the first new ingredient for OTC sunscreen ...

Pregnancy may not be a risk factor for invasive melanoma or melanoma in situ, though women of reproductive age may be at an increased risk.

Skyrizi (risankizumab-rzaa) IL-23 inhibitor Treatment of children aged 6 years and older with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy, and for ...

The table below is a review of notable updates that occurred in June 2026 for investigational products in development (not an inclusive list). Click on the status to view our full coverage. BM-3103 ...